The Avacta share price (AVCT) has climbed 1,400%. Here’s what I’d do now

The biotech sector has been one to watch since Covid-19 arrived. Could the Avacta Group share price be the one to beat in 2021 after its big 2020 surge?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Companies involved in Covid-19 testing have done well during the pandemic — and that includes Avacta Group (LSE: AVCT). The company released an update on its SARS-CoV-2 antigen lateral flow test on Monday, and the shares picked up 4% on the day. But that’s only a small part of the story — the Avacta share price has climbed a staggering 1,400% since the beginning of 2020.

We do need to see that in perspective, mind. Before Covid-19 turned up, there obviously wasn’t much call for Covid-19 testing. And Avacta was getting along with its cancer therapies and diagnostics. So a big boost to the Avacta share price since then is perhaps not surprising. But can it be sustained, and is there more growth to come?

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

First, let’s look at the latest news. The company mentions “recently announced data from a clinical study on 98 positive COVID-19 samples that demonstrate excellent performance in identifying the SARS-CoV-2 virus across a broad range of viral loads“. Avacta goes on to say it “expects to receive confirmation of the registration of the AffiDX in-vitro diagnostic device in the coming days, which will allow the group to immediately place the test on the market“.

Better than the competition

Chief executive Dr Alastair Smith added that, compared to two other commercially available lateral flow antigen tests, “the AffiDX test had better clinical sensitivity across the range of Ct values tested and, in particular, at lower viral loads“.

I take two immediate thoughts from that. The first is that the Avacta share price has gone on its sky-high, 1,000%+, ride even before the company had a saleable Covid-19 test. Wow! But secondly, if the Avacta test works better at lower viral loads, it could turn out to be very important indeed. Current lateral flow tests are not as accurate as laboratory tests that can take up to a couple of days to perform.

But where will the Avacta Group share price go for the rest of 2021 and beyond? Fellow Motley Fool writer Andy Ross recently suggested we could see another strong run in May. He could be right. I wouldn’t be surprised to see another leap upwards when the AffiDX test gets its expected approval. So would I buy the shares now?

Well, if ever there was a case where ‘past performance is no guide to future performance’ was apt, this is surely it. And I would not invest based solely on the short-term performance of anything. Saying that, there’s a good chance that Covid-19 will be with us long-term, just like influenza. And I can see demand for Covid-19 testing continuing for many more years.

Avacta share price valuation

But there’s another thing that puts me off high-flying growth shares like this. Avacta reported an operating loss in 2020, largely due to R&D spend. That makes it impossible for me to put any kind of rational valuation on the company. Is today’s price good value compared to future profits? Or is the Avacta share price pumped up much higher than it’s worth?

I have no idea, and I’ll keep away from the risk that comes with such uncertainty. But for any brave investors taking the chance, I wish them well.

FREE REPORT: Why this £5 stock could be set to surge

Are you on the lookout for UK growth stocks?

If so, get this FREE no-strings report now.

While it’s available: you'll discover what we think is a top growth stock for the decade ahead.

And the performance of this company really is stunning.

In 2019, it returned £150million to shareholders through buybacks and dividends.

We believe its financial position is about as solid as anything we’ve seen.

  • Since 2016, annual revenues increased 31%
  • In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259
  • Operating cash flow is up 47%. (Even its operating margins are rising every year!)

Quite simply, we believe it’s a fantastic Foolish growth pick.

What’s more, it deserves your attention today.

So please don’t wait another moment.

Get the full details on this £5 stock now – while your report is free.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Should you invest the value of your investment may rise or fall and your Capital is at Risk. Before investing your individual circumstances should be considered, so you should consider taking independent financial advice.

More on Investing Articles

Woman looking at a jar of pennies
Investing Articles

I think the JD Sports share price is a bargain. Here’s why

Our writer explains why the JD Sports share price has led him to buy more for his portfolio.

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is this tech stock one of the best shares to buy now?

Jabran Khan is on the hunt for the best shares to buy now for his holdings and takes a closer…

Read more »

Business development to success and FTSE 100 250 350 growth concept.
Investing Articles

3 top FTSE 250 shares to buy right now

I think the FTSE 250 is offering some great dividend and growth shares at the moment. And there are plenty…

Read more »

Happy retired couple on a yacht
Investing Articles

This growth stock has seen its shares pull back! Should I buy now?

When a growth stock sees its share price drop, I look carefully to see if I could pick up a…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How to identify the best income shares like this one

Income shares vary in quality but this approach keeps me from making some of the worst howlers with dividend investing.

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

If I’d invested £1k in Tesla shares a year ago, here’s how much I’d have now

If Jon Smith had bought Tesla shares a year ago, he'd be in profit. But he has some concerns for…

Read more »

Twenty pound notes in back pocket of jeans
Investing Articles

Should I buy tobacco shares now for big dividends?

After a possible setback for electronic cigarettes, our writer explains why he would still buy tobacco shares for his income…

Read more »

a couple embrace in front of their new home
Investing Articles

3 FTSE shares I’m buying with the Help to Build scheme!

Last week, the government launched a new, Help to Build scheme. So, here are three FTSE shares that could benefit…

Read more »